國家衛生研究院 NHRI:Items for Author

Year

Loading year class tree, please wait....

Items for Author "Su, YY"

Return to Browse by Author

Showing 46 items.

Collection	Date	Title	Relation
[姜乃榕] 會議論文/會議摘要	2021-09	A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer	-
[姜乃榕] 期刊論文	2022-06	Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin	-
[姜乃榕] 期刊論文	2022-04-15	The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan	-
[姜乃榕] 期刊論文	2019-10-05	Percutaneous computed tomography-guided coaxial core biopsy for the diagnosis of pancreatic tumors	-
[莊紹源] 期刊論文	2024-02-15	Examining arterial pulsation to identify and risk-stratify heart failure subjects with deep neural network	-
[蘇勇曄] 會議論文/會議摘要	2023-11	Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome	-
[蘇勇曄] 會議論文/會議摘要	2023-11	Single-cell RNA sequencing via Endoscopic Ultrasoundguided Fine-Needle Biopsy (EUS-FNB) Pancreatic Biopsies uncovered an aggressive subclone with a poor prognosis	-
[蘇勇曄] 會議論文/會議摘要	2023-06	Aristolochic acid (AA) exposure and telomere maintenance mechanism in liver angiosarcoma (AS)	-
[蘇勇曄] 會議論文/會議摘要	2022-07	Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors	-
[蘇勇曄] 期刊論文	2024-11	Cytoplasmic lipid droplets predict worse prognosis in diffuse large B-cell lymphoma: Next-generation sequencing deciphering lipogenic genes	-
[蘇勇曄] 期刊論文	2024-11	Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis	-
[蘇勇曄] 期刊論文	2024-08-28	Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab	-
[蘇勇曄] 期刊論文	2024-06	Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation	-
[蘇勇曄] 期刊論文	2024-02-01	Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma- with emphasis on locoregional therapy for oligoprogression	-
[蘇勇曄] 期刊論文	2023-06	Investigation into the content of red material in EUS-guided pancreatic cancer biopsies	-
[蘇勇曄] 期刊論文	2023-03	Tissue quality comparison between heparinized wet suction and dry suction in endoscopic ultrasound-fine needle biopsy of solid pancreatic masses: A randomized crossover study	-
[蘇勇曄] 期刊論文	2022-11-15	The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma	-
[蘇勇曄] 期刊論文	2022-09-21	Clustering of chromatin remodeling enzymes predicts prognosis and clinical benefit of therapeutic strategy in pancreatic cancer	-
[蘇勇曄] 期刊論文	2021-11-20	Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study	-
[蘇勇曄] 期刊論文	2021-08	Adjuvant versus neoadjuvant immunotherapy for hepatocellular carcinoma: Clinical and immunologic perspectives	-
[邱亞文(2005-2013)] 期刊論文	2009-09	Climate change and food security in East Asia	-
[邱亞文(2005-2013)] 期刊論文	2009-09	The nature of international health security	-
[鄒小蕙] 會議論文/會議摘要	2023-06	Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics	-
[陳立宗] 會議論文/會議摘要	2022-10	Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression	-
[陳立宗] 會議論文/會議摘要	2022-07	Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience	-
[陳立宗] 會議論文/會議摘要	2022-07	A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer	-
[陳立宗] 期刊論文	2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	-
[陳立宗] 期刊論文	2024-05	Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer	-
[陳立宗] 期刊論文	2024-02-15	Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway	-
[陳立宗] 期刊論文	2024-02-13	Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan	-
[陳立宗] 期刊論文	2023-09-01	The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study	-
[陳立宗] 期刊論文	2023-08-15	Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination	-
[陳立宗] 期刊論文	2023-02-05	Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer	-
[陳立宗] 期刊論文	2023-02	The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan	-
[陳立宗] 期刊論文	2022-10	Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study	-
[陳立宗] 期刊論文	2022-06-22	Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study	-
[陳立宗] 期刊論文	2022-06-02	Trial Designs for integrating novel therapeutics into the management of intermediate-stage hepatocellular carcinoma	-
[陳立宗] 期刊論文	2022-05-15	Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience	-
[陳立宗] 期刊論文	2022-04	A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study	-
[陳立宗] 期刊論文	2022-02-24	Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway	-
[陳立宗] 期刊論文	2020-12-29	Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan	-
[陳立宗] 期刊論文	2020-11-13	The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.]	-
[陳立宗] 期刊論文	2020-10	Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study	-
[陳立宗] 期刊論文	2020-05-04	The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort	-
[陳立宗] 期刊論文	2015-08	Primary gastrointestinal stromal tumor of the liver in an anorectal melanoma survivor: A case report	-
[陳美惠] 期刊論文	2024-08-02	Long-term effects on growth in preterm and small for gestational age infants: A national birth cohort study	-

Loading...

Category

Year

Items for Author "Su, YY"